We believe health data is underutilized. We use real-world patient data to enable personalized healthcare paths for our clients to improve their quality of life. Therefore, we develop digital biomarkers.
Digital biomarkers are defined as objective, quantifiable physiological and behavioral data. They are collected and measured by means of digital devices such as portables, wearables, implantables or digestibles.
Clinical validated digital biomarkers provide objective data that provides clinically significant results. This enables decision support to clinicians and will optimize patients’ health paths.
Elderly lung cancer patients are often over and undertreated due to the combination of standard treatment protocols in a highly heterogeneous patient population and the lack of a widely adopted monitoring solution to balance treatment…
As of November 7th 2023, we are releasing a major update to the KRANE platform, the web portal and the Orikami app. Important features of this Albatros release are a self-service module for creating projects…
